The neuronal transporter gene SLC6A15 confers risk to major depression.

Genomic context of the associated region on 12q21.31(A) Relevant features of the genomic architecture of a 3 Mb region comprising the 450 kb region of association with MD according to the UCSC Genome Browser: RefSeq annotated genes (blue), human mRNAs and expressed sequence tags from GenBank (black), HapMap Linkage Disequilibrium (red: high LD, white: low LD) and hotspots of homologous recombination from SNP genotyping data provided by HapMap and Perlegen (black). The associated region did not map to any known gene (compare with 2B). The flanking next genes to the region of association are SLC6A15 (+287 kb), a solute carrier family 6 gene that codes for a sodium-dependent branched amino acid transporter with high gene expression in neurons of the brain and TMTC2 (−989 kb), the transmembrane and tetratricopeptide repeat containing 2 gene of unknown function (see also tab. S1). (B) The negative common logarithm (−log10) of the best model p-values (y-axis) of all tested SNPs in the shown region from genome-wide case-control association testing in the discovery sample were plotted against the SNP’s chromosome positions (x-axis). The horizontal line across the figure indicates the genome-wide significance level of the experiment. The dot above this line represents the -log10 p-value of rs1545843. The corresponding Manhatten plot over all tested SNPs and chromosomes is shown in fig. S2.

LD structure of the 8 SNPs associated with MD on 12q21.31 is presented in (A) German controls of the GWAS in MD (N=366); and (B) in the African-American control sample (BDI<14, N=284). Pairwise r-squared values multiplied with 100 are shown for each SNP pair. rs1545843 (SNP 2) which reached experiment-wide significance in the GWAS, is in medium LD with the other seven associated SNPs in Europeans, but in low LD in African-Americans (SNP 1).

Forest plot of the combined meta-analysis over six independent studiesrs1545843 remained genome-wide significantly associated with MD in the meta-analysis after replication round 1 under the recessive model (AA vs. AG+GG, see tab. 1). This association was further replicated in the RANDIANT/WTCCC2 sample. The combined meta-analysis p-value over a total of 7 samples was 1.41e-09. MARS: The Munich antidepressant response signature study, the German GWAS discovery case-control MD sample (N=353/366). Munich recurrent depression: The Southern German recurrent depression and control replication sample (N=917/1022). ERF: The Dutch Erasmus Rucphen Family study MD case-control subsample (N=283/290) Emory: The African-American MD case-control subsample from Emory University in Atlanta (N=307/684). Bonn: West German MD case-control replication sample (N=292/1157)(Rietschel et al., 2010). MARS2: Additional MD cases and controls from the MARS study which were recruited after the GWAS (N=300/236). RADIANT/WTCCC2: UK-cases and controls of the RADIANT study and additional controls from the WTCCC2 cohorts (N=1636/7246).

SLC6A15 mRNA expression per rs1545843 genotype group measured in pre-mortem human hippocampus from individuals with temporal lobe epilepsy of European descent. (A) The MD risk genotype (AA) is associated with reduced full-length (FL, red boxes in part B) SLC6A15 mRNA expression levels compared to the non-risk genotypes (AG+GG). None of the other genes flanking the region of association with MD showed experiment-wide significant rs1545843 genotype-specific alterations in expression levels. SLC6A15 S: Short mRNA isoform of SLC6A15; (B) Box plot diagrams of FL (red) and S (blue) SLC6A15 mRNA expression levels in human hippocampus. On the x-axis the 3 genotype groups of rs1545843 are plotted against normalized SLC6A15 mRNA levels on the y-axis (group means: solid horizontal lines). Blue box-plots depict the expression levels of the short SLC6A15 isoform (S) and red plots expression levels of the full-length (FL) SLC6A15 transcript. For results of an analogues eQTL analysis in lymphoblastoid cell lines of HapMap individuals see supplemental fig. S3.

NMR imaging: Genotype-by-diagnosis interaction effects on hippocampal volume(a) Based on cytoarchitectonic probability maps, automated volumetry of grey matter (GM) of the total hippocampus (cornu ammonis, subiculum and dentate gyrus) and respective subregions was performed in 390 subjects after optimized segmentation and coregistration. The resulting maximum probability maps projected on a standard brain template in atlas space are shown. (b) Results of the left total hippocampal GM: Bars show adjusted mean values and one standard error of the mean for the main effect of diagnosis and the rs1545843 genotype (AA vs. AG/GG) × diagnosis interaction effect. Lowest mean volumes were seen for patients with the AA genotype. (c) Corresponding depiction for the left cornu ammonis (* nominal p<0.05, ** Bonferroni corrected p<0.05.). Results of other subregions and of right hemisphere are reported in tab. S2.

Reduced hippocampal SLC6A15 mRNA expression in stress susceptible mice(A) The significant reduction in SLC6A15 mRNA levels in the CA1 hippocampal region between stress resilient (R) and susceptible (S) mice detected by microarray analysis could be confirmed by in situ hybridisation (N=9/9, −2.1-fold reduction). (B) Two representative autoradiographs of hippocampal slices from one animal per group are shown. (C,D) SLC6A15 mRNA was also significantly reduced in the dentate gyrus (DG, −1.5-fold) and by trend reduced in the visual cortex (Cx, −1.7-fold). + P<0.06; **P<0.01; ***P<0.001. See also fig. S5 for description of the mouse model and tab. S3 for microarray results.